US4053626A
(en)
*
|
1973-03-13 |
1977-10-11 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Cholesterol level-lowering phenoxyacetic acids
|
US5830887A
(en)
*
|
1992-05-19 |
1998-11-03 |
Novogen Research Pty. Ltd. |
Health supplements containing phyto-oestrogens, analogues or metabolites thereof
|
US5446061A
(en)
*
|
1993-11-05 |
1995-08-29 |
Eli Lilly And Company |
Methods for lowering serum cholesterol
|
US5407955A
(en)
*
|
1994-02-18 |
1995-04-18 |
Eli Lilly And Company |
Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease
|
US5446071A
(en)
*
|
1994-11-18 |
1995-08-29 |
Eli Lilly And Company |
Methods for lowering serum cholesterol
|
AU4329296A
(en)
*
|
1995-01-13 |
1996-07-31 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative treatment
|
AUPO203996A0
(en)
*
|
1996-08-30 |
1996-09-26 |
Novogen Research Pty Ltd |
Therapeutic uses
|
US5994390A
(en)
*
|
1996-10-28 |
1999-11-30 |
Novo Nordisk |
Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
ZA979644B
(en)
*
|
1996-10-28 |
1998-04-28 |
Novo Nordisk As |
Heterocyclic compounds, compositions and uses.
|
CA2270055A1
(en)
*
|
1996-10-28 |
1998-05-07 |
Novo Nordisk A/S |
Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
IL129622A0
(en)
*
|
1996-10-28 |
2000-02-29 |
Novo Nordisk As |
Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
US5958967A
(en)
*
|
1996-10-28 |
1999-09-28 |
Novo Nordisk A/S |
Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
US5919817A
(en)
*
|
1996-10-28 |
1999-07-06 |
Novo Nordisk A/S |
Cis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
IL129626A0
(en)
*
|
1996-10-28 |
2000-02-29 |
Novo Nordisk As |
Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
US5985306A
(en)
*
|
1996-10-28 |
1999-11-16 |
Novo Nordisk A/S |
(+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes
|
US6316494B1
(en)
|
1996-10-28 |
2001-11-13 |
Novo Nordisk A/S |
cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
CA2270111A1
(en)
*
|
1996-10-28 |
1998-05-07 |
Lise Brown Christiansen |
Novel (-)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
AU4772097A
(en)
*
|
1996-10-28 |
1998-05-22 |
Novo Nordisk A/S |
Novel (cis)-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
IL129618A0
(en)
*
|
1996-10-28 |
2000-02-29 |
Novo Nordisk As |
Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
CA2269936A1
(en)
*
|
1996-10-28 |
1998-05-07 |
Lise Brown Christiansen |
Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
AU4772397A
(en)
*
|
1996-10-28 |
1998-05-22 |
Novo Nordisk A/S |
Novel (cis)-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
US6043269A
(en)
*
|
1996-10-28 |
2000-03-28 |
Novo Nordisk A/S |
cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
US6146668A
(en)
|
1997-04-28 |
2000-11-14 |
Novogen, Inc. |
Preparation of isoflavones from legumes
|
US6340703B1
(en)
*
|
1997-05-01 |
2002-01-22 |
Novogen, Inc. |
Treatment or prevention of osteoporosis
|
AUPP112497A0
(en)
*
|
1997-12-24 |
1998-01-22 |
Novogen Research Pty Ltd |
Compositions and method for protecting skin from UV induced immunosupression and skin damage
|
AUPP260798A0
(en)
|
1998-03-26 |
1998-04-23 |
Novogen Research Pty Ltd |
Treatment of medical related conditions with isoflavone containing extracts of clover
|
KR20000001793A
(ko)
*
|
1998-06-13 |
2000-01-15 |
이경하 |
신규한 벤조피란 또는 티오벤조피란 유도체
|
AUPP868599A0
(en)
*
|
1999-02-15 |
1999-03-11 |
Novogen Research Pty Ltd |
Production of isoflavone derivatives
|
AUPQ266199A0
(en)
*
|
1999-09-06 |
1999-09-30 |
Novogen Research Pty Ltd |
Compositions and therapeutic methods involving isoflavones and analogues thereof
|
US20090233999A1
(en)
*
|
1999-09-06 |
2009-09-17 |
Novogen Research Pty Ltd |
Compositions and therapeutic methods involving isoflavones and analogues thereof
|
AUPQ520300A0
(en)
*
|
2000-01-21 |
2000-02-17 |
Novogen Research Pty Ltd |
Food product and process
|
US7214706B2
(en)
|
2000-03-01 |
2007-05-08 |
Akzo Nobel N.V. |
Chroman derivatives as estrogenic compounds
|
AUPR363301A0
(en)
*
|
2001-03-08 |
2001-04-05 |
Novogen Research Pty Ltd |
Dimeric isoflavones
|
US20050119301A1
(en)
*
|
2001-03-16 |
2005-06-02 |
Alan Husband |
Treatment of restenosis
|
CN1902213B
(zh)
*
|
2003-11-18 |
2010-06-23 |
诺沃根研究股份有限公司 |
异黄酮类前药、其组合物和涉及它们的治疗方法
|
AU2004290613B2
(en)
*
|
2003-11-18 |
2010-03-25 |
Novogen Research Pty Ltd |
Isoflavonoid prodrugs, compositions thereof and therapeutic methods involving same
|
CN101056868B
(zh)
*
|
2004-09-21 |
2012-05-02 |
马休爱德华兹股份有限公司 |
取代的苯并二氢吡喃衍生物、药物及其在治疗中的应用
|
US8080675B2
(en)
|
2004-09-21 |
2011-12-20 |
Marshall Edwards, Inc. |
Chroman derivatives, medicaments and use in therapy
|
JP6013349B2
(ja)
|
2010-11-01 |
2016-10-25 |
メイ ファーマ, インク.Mei Pharma, Inc. |
癌の処置のためのイソフラボノイド化合物および方法
|
HUE054998T2
(hu)
|
2015-02-02 |
2021-10-28 |
Mei Pharma Inc |
Kombinációs terápiák emlõrák kezelésében való alkalmazásra
|